Status:
COMPLETED
The Ottawa AF Cardioversion Protocol
Lead Sponsor:
David Birnie
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Atrial fibrillation is an abnormal heart rhythm in which the top chambers of the heart (the atrial chambers) beat very fast. Electrical cardioversion is a technique to convert heart rhythm from AF to ...
Detailed Description
Study design: All eligible and consenting patients will undergo elective electrical cardioversion for atrial fibrillation (AF) using the Ottawa AF protocol.The fact that the physician follows the pro...
Eligibility Criteria
Inclusion
- Documented atrial fibrillation within last 12 months
- On continuous systemic oral anticoagulation for 28 days prior to the day of cardioversion or must have undergone a recent (\< 48 hrs) trans-esophageal echocardiogram prior to the day of cardioversion
- Able to provide informed consent
Exclusion
- Presence of intracardiac thrombus
- Pregnancy
Key Trial Info
Start Date :
August 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
389 Patients enrolled
Trial Details
Trial ID
NCT02192957
Start Date
August 1 2015
End Date
April 1 2018
Last Update
October 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institution
Ottawa, Ontario, Canada, K1Y 4W7